Error: Could not add to watchlist. X
+ Watchlist

Cyprotex PLC

CRX:LN
Acquired
CRX:LN was acquired by EVT:GR
160.50
GBp
As of 2:30 AM EST 12/14/2016
Volume
0
52Wk Range
91.50 - 160.50
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
52Wk Range
91.50 - 160.50
YTD Return
0.00%
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-0.14
Market Cap (m GBp)
36.127
Shares Outstanding (m)
22.509
Price/Sales (TTM)
2.07
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.45%
% Price Change
-0.52%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Cyprotex plc is a drug discovery company. The Group uses experimental screening, virtual screening and discovery partnerships to identify pre-clinical drug candidates.
Address
15 Beech Lane Macclesfield
Cheshire, SK10 2DR
United Kingdom
Phone
44-1625-505-100
Show More